InVitria launches Zap-SR as substitute to address bovine serum shortage
FORT COLLINS - InVitria announced the commercial launch of its Zap-SR (Serum Reducer), a product for cell culture customers who currently use fetal bovine serum and are concerned about... Read More
Wednesday November 26, 2014 0 comments
InVitria stem cell technology to be highlighted in Journal of Biotechnology
FORT COLLINS - InVitria , a division of Ventria Bioscience , announced the publication of new research demonstrating InVitria's animal-component-free recombinant human leukemia inhibitory factor... Read More
Tuesday January 7, 2014 0 comments
Ventria's Optiferrin shown functionally comparable to human transferrin in published study
FORT COLLINS - Ventria Bioscience's Optiferrin recombinant human transferrin has been shown functionally comparable to purified human transferrin in a study just published by the journal BMC... Read More
Friday December 14, 2012 0 comments
Ventria Bioscience: Study shows Optiferrin is comparable to human transferrin
FORT COLLINS - Ventria Bioscience announced that its Optiferrin product has been shown to be biochemically and structurally similar to human transferrin molecules derived from human serum or a... Read More
Tuesday October 9, 2012 0 comments
InVitria receives $1.5 million grant for cell-based vaccines
FORT COLLINS - InVitria, a division of Ventria Bioscience, announced it will receive $1.5 million over two years to develop a novel, animal-free, defined cell culture media for the commercial... Read More
Wednesday May 30, 2012 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
